What Researchers Did
Researchers reviewed and discussed emerging trends and new indications for hyperbaric oxygen therapy (HBOT).
What They Found
The review identified maturing clinical evidence supporting HBOT for sudden hearing loss, various problematic chronic wound states, and preventing or treating diabetes-related end-organ damage. However, the use of HBOT for mild traumatic brain injury sequelae remains controversial, despite biological plausibility and specific effects on immunological and metabolic pathways.
What This Means for Canadian Patients
Canadian patients with conditions like sudden hearing loss, chronic non-healing wounds, or diabetes-related complications may find HBOT beneficial where evidence supports its use. It is crucial for patients to consult their healthcare providers to determine if HBOT is an appropriate and evidence-based treatment option for their specific condition.
Canadian Relevance
This study does not have a specific Canadian connection.
Study Limitations
As a review, this study's findings are dependent on the quality and availability of existing clinical evidence for emerging hyperbaric oxygen therapy indications.